Sector consensus Genmab A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 05:39:26 15/01/2026 pm IST			5-day change	1st Jan Change
2,225.00 ^DKK	-1.16%		+3.63%	+9.92%

12:38pm	Jyske Bank Raises Genmab Target Price to 2,300 Danish Kroner (2,000), Reiterates Hold - BN	FW
14/01	Genmab A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:45 PM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
GENMAB A/S			DKK 2,154.69	-4.28%	12
ARGENX SE			€824.2	+19.31%	15
WUXI APPTEC CO., LTD.			CN¥128.37	+24.15%	18
INSMED INCORPORATED			$215.78	+32.01%	18
BIONTECH SE			$117.98	+26%	19
WUXI BIOLOGICS (CAYMAN) INC.			HK$36.25	+1.29%	25
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			HK$532.76	+14.23%	17
AKESO, INC.			HK$154.69	+39.7%	21
SUMMIT THERAPEUTICS INC.			$24.26	+84.86%	13
EXELIXIS, INC.			$45.61	+0.84%	18
MADRIGAL PHARMACEUTICALS, INC.			$612.64	+21.26%	14
ARROWHEAD PHARMACEUTICALS, INC.			$78.2	+18.65%	10
REMEGEN CO., LTD.			HK$75.17	-9.8%	15
NUVALENT, INC.			$141.71	+31.4%	17
CYTOKINETICS, INCORPORATED			$88.22	+36.57%	18
ABL BIO INC.			₩1,24,500	-35.22%	6
MERUS N.V.	-	-	-	-	-
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.			CN¥112.3	+9.88%	2
Average			7,637.81	+18.29%	15
Weighted average by Cap.			3,299.43	+20.64%	16